(Q38925703)

7 September 2017

title

Artemether or artesunate followed by mefloquine as a possible treatment for multidrug resistant falciparum malaria (English)

1 reference

7 September 2017

0 references

Plasmodium falciparum

0 references

malaria

1 reference

inferred from title

multiple drug resistance

1 reference

1 reference

1 reference

Bunnag D

1

1 reference

7 September 2017

Kanda T

2

1 reference

7 September 2017

Karbwang J

3

1 reference

7 September 2017

Thimasarn K

4

1 reference

7 September 2017

Pungpak S

5

1 reference

7 September 2017

Harinasuta T

6

1 reference

7 September 2017

publication date

1 July 1996

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

7 September 2017

published in

1 reference

7 September 2017

volume

90

1 reference

7 September 2017

issue

4

1 reference

7 September 2017

page(s)

415-417

1 reference

Malaria prophylaxis: guidelines for travellers from Britain. Malaria Reference Laboratory of the Public Health Laboratory Service, London

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990529-5

7 January 2021

The current status of drug resistance in malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990529-5

7 January 2021

Artemether-mefloquine combination in multidrug resistant falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990529-5

7 January 2021

A comparative clinical trial of two different regimens of artemether plus mefloquine in multidrug resistant falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990529-5

7 January 2021

Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2896%2990529-5

7 January 2021

10.1016/S0035-9203(96)90529-5

Identifiers

DOI

1 reference

7 September 2017

1 reference